COVID-19 drugs case: Supreme Court won’t stay proceedings against Gambhir foundation

Individuals cannot monopolise distribution of drugs during pandemic when medicines are scarce, it says

July 26, 2021 05:21 pm | Updated 06:38 pm IST - New Delhi

BJP MP Gautam Gambhir. File

BJP MP Gautam Gambhir. File

The Supreme Court on Monday refused to entertain a plea by BJP MP Gautam Gambhir’s foundation to stay the proceedings in a case of illegal procurement and distribution of COVID-19 drugs, saying individuals cannot monopolise the distribution of drugs during the pandemic when medicines were scarce.

“People were going helter-skelter to procure drugs during the second wave. And then suddenly, one person started distributing drugs. This is not done,” Justice D.Y. Chandrachud observed orally.

Justice M.R. Shah, also on the Bench, objected to the submissions of the foundation's lawyer, senior advocate Kailash Vasdev, that his client was working for people.

Mr. Vasdev sought a stay of the proceedings initiated under the Drugs and Cosmetics Act

“We saw how the common man was suffering. Individuals cannot distribute drugs... Do you want us to go into the merits of this case?,” Justice Shah asked the lawyer.

Justice Chandrachud expressed the court’s puzzlement of the sudden coming of existence of a foundation that assures people of life-saving COVID-19 medicines.

Justice Shah said, “We do not want to say anything... We too have our ears to the ground”.

‘Move HC for relief’

The Bench advised the foundation to move the Delhi High Court for relief. Mr. Vasdev withdrew the case.

The Delhi government’s drug controller had accused the foundation in the High Court of unauthorisedly stocking, procuring and distributing the Fabiflu medicine for COVID-19 patients.

The High Court had deprecated the manner in which a huge quantity of the drug was procured. It had said how genuine patients who needed the medicine at that particular time could not get it as the bulk stock was taken away by cricketer-turned-politician Gambhir.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.